Position in NVO
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,333,316
+$1,614,298 QoQ
Shares Held
69,531
+48.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#282
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KENNEDY INVESTMENT GROUP, INC. holds $14,260,907 across 7 Drug Manufacturers - General names. NVO ranks #2 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
15,754 | $3,964,336 | |
| 2 | NVO |
Novo Nordisk A S
This page
|
69,531 | $3,333,316 | |
| 3 | LLY |
ELI LILLY & Co
|
2,744 | $3,291,236 | |
| 4 | JNJ |
Johnson & Johnson
|
6,591 | $1,673,916 | |
| 5 | NVS |
Novartis AG
|
5,972 | $935,931 | |
| 6 | AMGN |
Amgen Inc
|
1,946 | $704,685 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,782 | $357,487 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,333,316 | 69,531 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,719,018 | 46,776 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,000,911 | 19,672 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||